2022 PDA/FDA Joint Regulatory Conference
September 12-14, 2022 | Washington, D.C.
The Parenteral Drug Association (PDA) and the U.S. Food and Drug Administration (FDA) are once again co-sponsoring the PDA/FDA Joint Regulatory Conference, which is now in its 31st year. This flagship conference provides opportunities for attendees to learn about current issues relating to manufacturing and quality assurance. Consider attending and stop by Table 18 to discuss your Parenteral Packaging needs with us.
Residual Seal Force Tester
The Genesis Residual Seal Force Tester evaluate's seal tightness by measuring the Residual Seal Force in the stopper/seal combination of a parenteral package created as a result of the vial sealing process.
The FDA recognizes the use of RSF as a predictor of seal integrity.
The FDA in its Guidance for Industry Container and Closure System Integrity Testing in Lieu of Sterility Testing as a Component of the Stability Protocol for Sterile Products recognizes the usefulness of properly validated seal force testing. Most importantly, RSF is useful in the establishment, validation and control of capping machine settings.
The Integra Laboratory Vial Crimper
Small Package, Big Performance
The Integra Laboratory Crimper is a small vial crimper that is ideal for development, pre-clinical, clinical, pilot and compounding pharmacy operations. Available in four configurations the Integra can meet your small batch size needs assuring the best possible seal integrity.